Given that STAT3 siRNAs decreased PD-L1 expression by only 10–32% in two KRAS-mutant lung adenocarcinoma cell lines23, it is possible that STAT3 only partially involved. The gene discussed is STAT3; the disease is lung adenocarcinoma.